Impaired estrogen-induced negative feedback on gonadotropin secretion in patients with gonadotropin-secreting and nonfunctioning pituitary adenomas

European Journal of Clinical Investigation

Volumn 32, Issue 5, 2002, Pages 335-340

  Lania, A ^a   Gangi, E ^a   Romoli, R ^a   Losa, M ^b   Travaglini, P ^c   Meringolo, D ^d   Ambrosi, B ^a   Faglia, G ^a   Beck Peccoz, P ^a   Spada, Anna ^a,e  

^a UNIVERSITY OF MILAN   (Italy)

^b Faculty of Medicine   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d Ospedale di Bentivoglio   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Estrogen; Gonadotropin; Gonadotropin secreting adenomas; Negative feedback; Non functioning pituitary adenomas

Indexed keywords

CORTICOTROPIN; ESTROGEN; ETHINYLESTRADIOL; FOLLITROPIN; GLUCOCORTICOID; GONADOTROPIN; LUTEINIZING HORMONE; SEX HORMONE; THYROID HORMONE; THYROTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; GONADOTROPIN RELEASE; GONADOTROPIN SECRETING PITUITARY ADENOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; LUTEINIZING HORMONE BLOOD LEVEL; MALE; NEGATIVE FEEDBACK; NONFUNCTIONING PITUITARY ADENOMA; PRIORITY JOURNAL; STEROID BLOOD LEVEL;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CHILD; ESTRADIOL CONGENERS; ETHINYL ESTRADIOL; FEEDBACK, BIOCHEMICAL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPINS, PITUITARY; HUMANS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; ORGANIZATION AND ADMINISTRATION; PITUITARY NEOPLASMS; THYROTROPIN-RELEASING HORMONE;

EID: 0036998239     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.00981.x     Document Type: Article

References (26)

1. Kwekkeboom DJ, de Jong FH, Lamberts SW. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. J Clin Endocrinol Metab 1989;68:1128-35.
2. Asa SL, Cheng Z, Ramyar L, Singer W, Kovacs K, Smyth HS et al. Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology. J Clin Endocrinol Metab 1992;74:1128-34.
3. Asa SL, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 1998;19:798-827.
4. Aylwin SJ, Welch JP, Davey CL, Geddes JF, Wood DF, Besser GM et al. The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas. J Clin Endocrinol Metab, 2001;86:2476-83.
5. Oppenheim DS, Kana AR, Sangha JS, Klibanski A. Prevalence of alpha-subunit hypersecretion in patients with pituitary tumors: clinically nonfunctioning and somatotroph adenomas. J Clin Endocrinol Metab 1990;70:859-64.
6. Nobels FR, Kwekkeboom DJ, Coopmans W, Hoekstra R, De Herder WW, Bouillon R et al. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas. J Clin Endocrinol Metab 1993;77:784-9.
7. Katznelson L, Alexander JM, Klibanski A. Clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 1993;76:1089-94.
8. Snyder PJ. Gonadotroph cell adenomas of the pituitary. Endocr Rev 1985;6:552-63.
9. Snyder PJ, Bashey HM, Kim SU, Chappel SC. Secretion of uncombined subunits of luteinizing hormone by gonadotroph cell adenomas. J Clin Endocrinol Metab 1984;59:1169-75.
10. Daneshdoost L, Gennarelli TA, Bashey HM, Savino PJ, Sergott RC, Bosley TM et al. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone. J Clin Endocrinol Metab 1993;77:1352-5.
11. Gil-del-Alamo P, Pettersson KS, Saccomanno K, Spada A, Faglia G, Beck-Peccoz P. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma. Clin Endocrinol 1994;41:661-6.
12. Friend JN, Judge DM, Sherman BM, Santen RJ. FSH-secreting pituitary adenomas: stimulation and suppression studies in two patients. J Clin Endocrinol Metab 1976;43:650-7.
13. Roman SH, Goldstein M, Kourides IA, Comite F, Bardin CW, Krieger DT. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt] LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor. J Clin Endocrinol Metab 1984;58:313-9.
14. Beck-Peccoz P, Medri G, Rossi CM, Gaiter A, Nebiolo PE, Alloatti Set al. Unusual association of gonadotropin-secreting pituitary microadenoma and chronic uremia in a young man. In: Gennazzani AR, Petraglia F, Volpe A, Facchinetti F, editors. Recent research in basic and clinical neuroendocrinology. Amsterdam: Elsevier Science Publishers BV;1988.pp. 295-302.
15. Ambrosi B, Bassetti M, Ferrario R, Medri G, Giannattasio G, Faglia G. Precocious puberty in a boy with a PRL-, LH- and FSH-secreting pituitary tumour: hormonal and immunocytochemical studies. Acta Endocrinol 1990;122:569-76.
16. Borgato S, Persani L, Romoli R, Cortelazzi D, Spada A, Beck-Peccoz P. Serum FSH levels in patients with gonadotropin secreting and nonfunctioning pituitary adenomas. J Endocrinol Invest 1998;21:372-9.
17. Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci USA 1998;95:6965-70.
18. Couse JF, Korach KS. Estrogen receptor null mice: what we learned and where will they lead us? Endocr Rev 1999;20:358-417.
19. Smith EP, Boyd J, Frank RG, Takahashi H, Cohen RM, Specker B et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;16:1056-106.
20. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female sibling caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80:3689-99.
21. Gharib SD, Wierman ME, Shupnik MA, Chin WW. Molecular biology of the pituitary gonadotropins. Endocr Rev 1990;11:177-99.
22. Shupnik MA, Pitt LK, Soh AY, Anderson A, Lopes MB, Laws ER Jr. Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors. J Clin Endocrinol Metab 1998;83:3965-72.
23. Chaidarun SS, Swearingen B, Alexander JM. Differential expression of estrogen receptor-beta (ER beta) in human pituitary tumors: functional interactions with ER alpha and a tumor-specific splice variant. J Clin Endocrinol Metab 1998;83:3308-15.
24. Ambrosi B, Giovine C, Nava C, Elli R, Faglia G. Serum gonadotrophin pulsatile secretion in men with Prl-secreting and non-secreting pituitary tumours. Acta Endocrinol (Copenh) 1985;109:1-6.
25. Sartorio A, Pizzocaro A, Liberati D, De Nicolao G, Veldhuis JD, Faglia G. Abnormal LH pulsatility in women with hyeperprolactinemic amanorrhea normalizes after bromocriptine treatment: a deconvolution-based assessment. Clin Endocrinol 2000;52:703-12.
26. Vaninetti S, Baccarelli A, Romoli R, Fanelli M, Faglia G, Spada A. Effect of aging on serum gonadotropin levels in healthy subjects and patients with nonfunctioning pituitary adenomas. Eur J Endocrinol, 2000;142:144-9.